Tezacaftor

Jan 06, 2020

New FDA-approved cystic fibrosis medicine, Trikafta®, among other specialty drugs available through AllianceRx Walgreens Prime

Nov 06, 2019

AllianceRx Walgreens Prime study demonstrates favorable adherence, but high cost for cystic fibrosis patients prescribed modulator medications

Oct 24, 2019

Proteostasis Therapeutics Announces Presentations Highlighting its CFTR Modulators at the North American Cystic Fibrosis Conference

Oct 21, 2019

FDA approves new breakthrough therapy for cystic fibrosis

Jun 21, 2019

FDA expands approval of treatment for cystic fibrosis to include patients ages 6 and older

May 08, 2019

Proteostasis Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update

Jun 25, 2018

Global Cystic Fibrosis Industry

Jun 01, 2018

Proteostasis Announces Presentations at the 41st European Cystic Fibrosis Society Conference

May 08, 2018

Proteostasis Announces Formation of Independent Steering Committee of Leading Experts to Advise on the Global Phase 3 Clinical Development Program for PTI-428 in Cystic Fibrosis

Apr 17, 2018

Proteostasis Receives Endorsement from the Cystic Fibrosis Foundation's Therapeutic Development Network for the Study of the Company's Amplifier, PTI-428, in CF Subjects on Background Symdeko(TM) Therapy